600 patients66,869 observations120 daysLIVE

Emergent Cluster EC-01NEW

30 patients

Response builds, then fades from the second month without a toxicity signal.

Emerges around
Day 60
Detectable by LIFE OS
Day 46
Median clinical recognition
Day 86
Potential lead time
40 days

Average trajectory of the cluster

mean of 30 trajectories · dashed = model expectation at baseline
solid = observed · dashed = predicted

Shared signals

  • response plateau by day ~35
  • no toxicity signal
  • adherence drift after day ~70
  • declining step count
Mean response
37
Mean GI score
18
Discontinuation risk
20%

Potential action

AD-05 appears associated with improved persistence among similar patients (+14% persistence, −2% symptom burden in synthetic history).

Members